why has teva stock dropped?
316269
Shares of the company were lower Thursday after an analyst from Bank of America Merrill Lynch downgraded the firm to Underperform from Buy, citing risks around the ongoing opioid litigation. ... Teva stock closed at $9.70 on May 29, a 10.8% drop from last Friday's close.
1067636
Shares of Vivus (VVUS) are down 7.12% to $5.74 after Piper Jaffray downgraded the stock earlier today to"underweight" from "neutral." ... (VVUS) - Get Report are down 7.12% to $5.74 after Piper Jaffray downgraded the stock earlier today to "underweight" from "neutral."
1052565
Apr 13, 2020 (Market Realist via COMTEX) -- Nvidia (NASDAQ:NVDA) stock fell over 1% in today's trading session at 9:50 AM ET. ... Also, the S&P 500 and the Nasdaq Composite lost about 1.4% and 0.8%, respectively. The broader indexes fell due to uncertainty amid COVID-19.
190508
The reduction is explained largely by losses on the disposal of assets from the “Bad Bank” and what RBS quaintly describe as “income attrition”. The shares dropped like a stone on the news, down 8% in early trade.
240437
Teva is no longer manufacturing Clonazepam. I have been on the Actavis for several years.
846159
AstraZeneca News: Why AZN Stock Is Sliding Lower Today. AstraZeneca (NYSE:AZN) stock is sliding more than 5% on Friday following the company's announcement that it had inked a deal to acquire the rights of a new cancer drug that will bolster its oncology branch. ... AZN stock is down about 5.9% on Friday.
894297
Warranty. Teva® offers a limited one year warranty. ... Any items sent to Teva® that are past the one year purchase date will be evaluated on a case-by-case basis. If your item meets warranty criteria, Teva® can offer an exchange or credit, but we do not perform repairs.
393720
DXC stock has declined this year, falling by roughly 50% year-to-date. ... Much of the decline in the stock price came in August after the company slashed its full-year earnings and revenue guidance citing currency headwinds, some pressure on its legacy businesses, and delays relating to some deals.
146031
As of January 1, the footwear maker is discontinuing its men's shoe collection and focusing on its women's lineup of shoes. The company is partnering with Teva to produce the new Ahnu by Teva collection, which is available on Teva's website.
763837
Between January 31st and April 16, LMT stock has lost 13% of its value (vs. about 14% decline in the S&P 500). A bulk of the decline came after March 6th, when an increasing number of Coronavirus cases outside China fueled concerns of a global economic slowdown.
1209595
Shares of pharma giant AbbVie (NYSE:ABBV) dipped by 3.96% over the course of 2019, according to data from S&P Global Market Intelligence. ... International sales of AbbVie's flagship arthritis medicine, Humira, dropped markedly in 2019 due to the launch of biosimilars in key territories.
1428861
QVAR Discontinued- Replaced by QVAR RediHaler Teva replaced QVAR with QVAR RediHaler in the first quarter of 2018. QVAR RediHaler contains the same active ingredient as QVAR and comes in the same doses (40 and 80 mcg).
464588
The stock fell over 8% during the Wednesday trading session to close at $107. Although much of their report was positive, the market continues to look for short term growth catalysts. The reason the market sold GWPH today was that they didn't make progress this quarter towards profitability.
358129
A. Yes, Teva Pharmaceuticals acquired Actavis Generics. The acquisition has allowed us to offer you even more generic drug options! Your patients may notice that some of the products we acquired still have Actavis labeling.
1394396
Unhappily, Amneal Pharmaceuticals had to report a 1566% decline in EPS over the last year. This was, in part, due to extraordinary items impacting earnings. In fact, it actually made a loss over the last twelve months. The share price fall of 75% isn't as bad as the reduction in earnings per share.
74193
Based on this lack of demand for the Teva product at the time, and to enable us to re-adjust our limited resources to make other life-saving products needed in the market, Teva decided to discontinue vincristine and alerted FDA of its decision in March 2019.
966969
Shares of AT&T (NYSE:T) have dropped today, down by 6% as of 11:30 a.m. EDT, after the company said it would cancel a previously announced stock buyback plan due to uncertainties around the COVID-19 pandemic.